Australian legislation to implement a new regulatory framework for human cellular and tissue based therapy products (HCTs) and other emerging biological therapies has been tabled in the House of Representatives1.
The Therapeutic Goods Amendment (2009 Measures No 3) Bill 2009 was introduced on 25 November by parliamentary secretary for health Mark Butler2...
Please login to read the full article.
